Epidemiological evidence reveals that lanthanum chloride exposure triggers hepatic steatosis in zebrafish larvae, suggesting serious environmental health risks.
Lanthanum (La), the second most produced rare earth element, is detected in various environmental and human samples. Epidemiological studies have reported a strong association between La exposure and liver injury. However, the effects of early La exposure on liver development and underlying mechanisms remain limited. Here, we evaluate the hepatotoxicity of LaCl₃ at environmentally relevant concentrations using zebrafish larvae. Embryonic LaCl₃ exposure causes concentration-dependent hepatic steatosis, which cannot be reversed after exposure cessation. Metabolomic profiling reveals that very-low-density lipoprotein (VLDL) and its multiple downstream metabolites are consistently downregulated upon LaCl₃ treatment, together with increased triglycerides (TG) level, indicating impaired TG-VLDL biosynthesis. In addition, transcriptomics suggest that genes related to the PPARα signaling pathway are significantly downregulated, especially those involved in TG-VLDL biosynthesis (mttp and all apob subtypes). Further studies show that LaCl₃ can inhibit the transcriptional regulatory activity of PPARα. The upregulation of the PPARα signaling pathway corresponding genes of ppara, mttp, and apob effectively rescues LaCl₃-induced liver impairments. Subsequently, a subcellular localization assay finds that increased ApoB degradation in the endoplasmic reticulum contributes to LaCl₃-triggered lipid droplet accumulation. Overall, our findings fill critical research gaps regarding LaCl₃-induced hepatotoxicity and provide important evidence for the environmental risk assessment of La.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: